Aarti Drugs soars on share buyback proposal

22 Aug 2024

Aarti Drugs soars on share buyback proposal

The announcement was made after market hours yesterday.

Aarti Drugs forms part of $6 Billion Aarti Group of Industries with robust R&D Division at Tarapur, Maharashtra Industrial Development Corporation (MIDC) in close vicinity to manufacturing locations. The company is engaged in the manufacturing of Active Pharmaceutical Ingredients (APIs), Pharma Intermediates, Speciality Chemicals and produces Formulations with its whollyowned subsidiary-Pinnacle Life Science Private.

The company's consolidated net profit declined 30.5% to Rs 33.24 crore on 16% slide in net sales to Rs 555.34 crore in Q1 FY25 over Q1 FY24.

Top Blogs

blog-article-image-one

Equity

blog-article-image-one

Share Market

Best Stocks To Buy Today

3 mins read . Aug 7, 2025

Join the Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions